Fat and Fatty Acid Intake and Metabolic Effects in the Human Body
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Review Articles| September 15 2009 Fat and Fatty Acid Intake and Metabolic Effects in the Human Body Subject Area: Endocrinology , Further Areas , Nutrition and Dietetics , Public Health T.A.B. Sanders T.A.B. Sanders Nutritional Sciences Division, King's College London, London, UK Search for other works by this author on: This Site PubMed Google Scholar Ann Nutr Metab (2009) 55 (1-3): 162–172. https://doi.org/10.1159/000229001 Article history Published Online: September 15 2009 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation T.A.B. Sanders; Fat and Fatty Acid Intake and Metabolic Effects in the Human Body. Ann Nutr Metab 1 September 2009; 55 (1-3): 162–172. https://doi.org/10.1159/000229001 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsAnnals of Nutrition and Metabolism Search Advanced Search This content is only available via PDF. © 2008 S. Karger AG, Basel2009Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 2×
“Lauric acid (C12: 0) raises LDL-C and HDL-C and decreases the TC:HDL-C ratio by –0.037 for each 1% energy when it replaces carbohydrates [Mensink et al., 2003].”
BackgroundInfluential(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“The ratio of TC:HDL-C (which indicates the ratio of apolipoprotein B:apolipoprotein A1) is twice as informative [Lewington et al., 2007] of individual CVD risk than TC or LDL-C, and differences in this ratio within and between populations are predominantly due to lifestyle factors (diet, physical…”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402 · cited 1×
“Chronic inflammation, as indicated by mild elevations of C-reactive protein, increases the risk of CVD – especially if the TC: HDL-C ratio is high [Ridker, 2001].”
BackgroundInfluence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391
Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170
Vessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 1×
“However, randomized controlled trials [Vessby et al., 2001; Griffin et al., 2006; Tardy et al., 2009] have generally failed to show any consistent effect of changing either the level of fat or the type of fat on insulin sensitivity when changes in weight or physical activ- ity are taken into…”
BackgroundEffect of a single high-fat meal on endothelial function in healthy subjects
Vogel, R. A., Corretti, M. C., & Plotnick, G. D. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00760-6 · Cited by 798
Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1286 · Cited by 776 · cited 1×
“One mechanism suggested is that postprandial lipaemia may increase the absorption of endotoxin from the gut [Erridge et al., 2007].”
BackgroundEffects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732
Plant sterol and stanol margarines and health
Law, M. (2000) · BMJ · doi:10.1136/bmj.320.7238.861 · Cited by 729 · cited 2×
“Plant sterols and stanols block the absorption of dietary and biliary cholesterol, and lower TC, LDL-C and the TC:HDL-C ratio independent of changes in fatty acid composition, but these effects are only significant following the consumption of food products fortified with plant sterols/stanols [Law, 2000].”
BackgroundInfluentialBlood pressure response to fish oil supplementation: metaregression analysis of randomized trials
Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R. T., & Kok, F. J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00010 · Cited by 700 · cited 1×
“High intakes ( 1 2 g/day) of n–3 LCP convincingly lower blood pressure [Geleijnse et al., 2002], and there is possible evidence that habitual intakes at lower levels have the same effect [Ueshima et al., 2007].”
BackgroundYu-Poth, S., Zhao, G., Etherton, T., Naglak, M., Jonnalagadda, S., & Kris-Etherton, P. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.4.632 · Cited by 584 · cited 1×
“Furthermore, weight loss in overweight or obese subjects results in improvements in circulating lipid concentrations, including raising HDL-C, lowering TAG and TC, and improving the TC:HDL-C ratio [Yu-Poth et al., 1999].”
BackgroundHeinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563 · cited 2×
“Elevated procoagulant FVII and fibrinogen and decreased indices of fibrinolytic activity (as assessed by measures of clot lysis time or elevated plasminogen activator inhibitor PAI-1 activity) are associated with an increased risk of atherothrombosis [Meade et al., 1993; Heinrich et al., 1994; Folsom et al., 2001].”
BackgroundBaer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476 · cited 2×
“There is possible evidence that TFA increase systemic inflammation [Baer et al., 2004], but not all studies have consistently shown such effects [MotardBélanger et al.”
BackgroundHigh-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis
Garg, A. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.577s · Cited by 428
Mozaffarian, D., & Clarke, R. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602976 · Cited by 410 · cited 1×
“Compared with carbohydrate, TFA raise LDL-C, but have a similar effect as carbohydrate on HDL-C [Mensink and Katan, 1990; Nestel et al., 1992; Judd et al., 1994; Almendingen et al., 1995; Aro et al., 1997; Lichtenstein et al., 1999; Sanders et al., 2003b; Mozaffarian and Clarke, 2009].”
BackgroundPostprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress
Bae, J.-H., Bassenge, E., Kim, K.-B., Kim, Y.-N., Kim, K.-S., Lee, H.-J., Moon, K.-C., Lee, M.-S., Park, K.-Y., & Schwemmer, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00601-8 · Cited by 373 · cited 2×
“Meals high in long-chain fatty acids, which induce substantial lipaemia compared with meals low in fat but high in carbohydrate, result in an impairment of endothelial function in the postprandial period in healthy subjects [Vogel et al. 1997, 2000; Ong et al., 1999; Bae et al., 2001; Cortés et al., 2006].”
BackgroundEffects of Different Forms of Dietary Hydrogenated Fats on Serum Lipoprotein Cholesterol Levels
Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., & Schaefer, E. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402501 · Cited by 352 · cited 1×
“Compared with carbohydrate, TFA raise LDL-C, but have a similar effect as carbohydrate on HDL-C [Mensink and Katan, 1990; Nestel et al., 1992; Judd et al., 1994; Almendingen et al., 1995; Aro et al., 1997; Lichtenstein et al., 1999; Sanders et al., 2003b; Mozaffarian and Clarke, 2009].”
BackgroundWeggemans, R. M., Zock, P. L., & Katan, M. B. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.5.885 · Cited by 333 · cited 2×
“A more recent metaanalysis [Weggemans et al., 2001] concluded that for most individuals over the range of practical intake (0–400 mg/ day), each 100 mg leads to increases in TC by 0.056 mmol/l (95% CI: 0.046–0.065 mmol/l) and HDL-C by 0.008 mmol/l (95% CI: 0.005–0.010 mmol/l), increasing the…”
BackgroundInfluentialChardigny, J.-M., Destaillats, F., Malpuech-Brugère, C., Moulin, J., Bauman, D. E., Lock, A. L., Barbano, D. M., Mensink, R. P., Bezelgues, J.-B., Chaumont, P., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.558 · Cited by 252
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215
Kelley, D. S., Siegel, D., Vemuri, M., & Mackey, B. E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.324 · Cited by 179
Vedin, I., Cederholm, T., Freund Levi, Y., Basun, H., Garlind, A., Faxén Irving, G., Jönhagen, M. E., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1616 · Cited by 171
Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year
BLOK, W. L., DESLYPERE, J. ‐., DEMACKER, P. N. M., VAN DER VEN‐JONGEKRIJG, J., HECTORS, M. P. C., VAN DER MEER, J. W. M., & KATAN, M. B. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2240775.x · Cited by 129 · cited 1×
“…intakes as may habitually be consumed in usual diets, have failed to demonstrate any clear effects on cytokines, adhesion molecules or C-reactive protein [Blok et al., 1997; Balk et al., 2006; Theobald Metabolic Effects of Fat and Fatty Acid Intake Ann Nutr Metab 2009;55:162–172 167 et al., 2007].”
BackgroundHarris, W., & Muzio, F. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.1.68 · Cited by 105 · cited 2×
“5 g n–3 LCP result in decreased postprandial lipaemia, both acutely and chronically [Harris and Muzio, 1993; Zampelas et al., 1994; Griffin et al., 2006], probably by way of their effects on reducing VLDL synthesis, which in turn reduces competition for clearance of chylomicron remnants.”
BackgroundInfluentialLDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.
Theobald, H. E., Chowienczyk, P. J., Whittall, R., Humphries, S. E., & Sanders, T. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.558 · Cited by 101
Self-citationGeppert, J., Kraft, V., Demmelmair, H., & Koletzko, B. (2006) · British Journal of Nutrition · doi:10.1079/bjn20051720 · Cited by 96
Cited by
de Oliveira Otto, M. C., Mozaffarian, D., Kromhout, D., Bertoni, A. G., Sibley, C. T., Jacobs, D. R., & Nettleton, J. A. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037770 · Cited by 364
Jebb, S. A., Lovegrove, J. A., Griffin, B. A., Frost, G. S., Moore, C. S., Chatfield, M. D., Bluck, L. J., Williams, C. M., & Sanders, T. A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29096 · Cited by 192
“The dietary interventions did not alter the proportion of small dense LDLs, which are believed to be the key proatherogenic lipoprotein particle associated with the dyslipidemia of metabolic syndrome, and this finding is consistent with previous reports (39, 40).”
ResultSelf-citationFats and fatty acid requirements for adults
Elmadfa, I., & Kornsteiner, M. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000228996 · Cited by 161
Metadata
- Authors
- Sanders, T. A. B.
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 55
- Issue
- 1-3
- Pages
- 162-172
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W1970239356
- Cited by
- 59
- References
- 30
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.